BioSpace News Archive

Pharm Country

LifeMD to Participate in Panel Presentation at LifeSci Partners Corporate Access Event 2022

LifeMD, Inc. today announced that Justin Schreiber, Chairman and Chief Executive Officer, will participate in a panel presentation at the LifeSci Partners Corporate Access Event, to take place virtually January 5th -7th , 2022.

December 30, 2021
·
3 min read
Deals

Biofrontera Inc. announces reduction of Biofrontera AG shareholding to less than 50% through warrant exercises

Biofrontera Inc. announced that through the exercise of outstanding warrants the majority ownership of Biofrontera AG was diluted below 50%. Biofrontera AG’s shareholding in Biofrontera Inc. of 8,000,000 shares is unchanged, but now represents approximately 47% of the currently outstanding shares.

December 30, 2021
·
3 min read
Trait Biosciences Advances Innovative Water-Soluble Cannabinoid Technology, Delivering Key Milestones in Series A Financing and Appoints Dr. Hanny Kanafani as Vice President

Trait Biosciences Inc. , a leading cannabinoid biotechnology research organization, announced that it has successfully completed key scientific studies and operational milestones associated with its Series A Financing.

December 30, 2021
·
4 min read
Contrast Media Market Size to Reach USD 6.79 Billion in 2028, Says Reports and Data

Growing technological advancements in diagnostic imaging systems, increasing prevalence of various chronic diseases globally, and rising healthcare spending are key factors fueling global market revenue growth.

December 30, 2021
·
8 min read
Lone Star Bio

Gibson Diagnostic Labs Supports Local Charity Organizations Through Annual Gibson Gives Event

Gibson Diagnostic Labs, a leading clinical diagnostic laboratory, hosted its inaugural fundraising event entitled “Gibson Gives” to raise money and supplies in support of various local charity organizations that benefit the homeless.

December 30, 2021
·
1 min read
Change in number of shares and votes in Biotage AB

As previously announced, Biotage AB has during December 2021 issued 243,252 new class C shares in accordance with the incentive program LTIP 2021 which was adopted by the Annual General Meeting held on April 28, 2021.

December 30, 2021
·
2 min read
Lone Star Bio

Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2 Diabetes

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for the marketing and sale of sotagliflozin.

December 30, 2021
·
5 min read
Policy

Centene and Magellan Satisfy All Regulatory Approvals for Completion of Acquisition Agreement

Centene Corporation (NYSE: CNC) and Magellan Health, Inc. (NASDAQ: MGLN) today announced that they have obtained all required regulatory approvals necessary to close Centene’s pending acquisition of Magellan Health.

December 30, 2021
·
9 min read
Biotech Bay

Silk Road Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference.

December 30, 2021
·
1 min read
FDA

Xeris Biopharma Announces U.S. FDA Approval of Recorlev® (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing’s Syndrome

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), today announced the U.S. Food and Drug Administration (FDA) approval of Recorlev® (levoketoconazole) for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an option or has not been curative.

December 30, 2021
·
15 min read